Experts from BJMC & SGH begin whole genome sequencing of CHIKV
Experts at BJMC and SGH are sequencing Chikungunya virus to investigate mutations linked to severe cases and outbreaks in ...
Pharmabiz5d
UK MHRA accepts Bavarian Nordic’s MAA for chikungunya vaccine, CHIKV VLP for persons aged 12 and older
Copenhagen, Denmark Monday, March 10, 2025, 11:00 Hrs [IST] ...
eLife3d
Exploring the repository of de novo-designed bifunctional antimicrobial peptides through deep learning
Peptides designed by artificial intelligence restrict both drug-resistant bacteria and rapidly evolving viruses.
Kennedy spends first month as health secretary downplaying vaccines and targeting food additives
A month into his role as health and human services secretary, Robert F. Kennedy Jr.'s moves on vaccines have worried health ...
Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older
Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...
Monthly Prescribing Reference25d
FDA Approves Vimkunya to Protect Against Chikungunya Virus
The accelerated approval was granted based on anti-CHIKV neutralizing antibody levels; continued approval may be contingent upon verification of benefit in a confirmatory trial. The Food and Drug ...
Physician's Weekly10d
Molecular Factors Driving Post-Chikungunya Chronic Joint Disease
The following is a summary of “Transcriptomic insights into early mechanisms underlying post-chikungunya chronic inflammatory ...
Business Insider14d
Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – ...
Medical Dialogues14d
Biological E collaborate with Bavarian Nordic to expand Chikungunya Vaccine access in low, middle income countries
Hyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian Nordic's Chikungunya Vaccine in low- and middle-income countries ...